Breast Cancer Research and Treatment

A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases
pp. 105-112(8)
Authors: Isasi, Carmen; Moadel, Renee; Blaufox, M.

Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk
pp. 113-115(3)
Authors: Langsenlehner, Uwe; Krippl, Peter; Renner, Wilfried; Yazdani-Biuki, Babak; Eder, Tanja; Köppel, Herwig; Wascher, Thomas; Paulweber, Bernhard; Samonigg, Hellmut

Clodronate treatment influences MMP-2 associated outcome in node positive breast cancer
pp. 117-125(9)
Authors: Leppä, S.; Saarto, T.; Vehmanen, L.; Blomqvist, C.; Elomaa, I.

Distinct breast cancer incidence and prognostic patterns in the NCI’s SEER program: suggesting a possible link between etiology and outcome
pp. 127-137(11)
Authors: Anderson, William; Jatoi, Ismail; Devesa, Susan

Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death
pp. 139-148(10)
Authors: Rakovitch, Eileen; Pignol, Jean-Philippe; Chartier, Carole; Ezer, Michelle; Verma, Sunil; Dranitsaris, George; Clemons, Mark

Genetic polymorphisms of TGF-1 & TNF- and breast cancer risk
pp. 149-155(7)
Authors: Lee, Kyoung-Mu; Park, Sue; Hamajima, Nobuyuki; Tajima, Kazuo; Yoo, Keun-Young; Shin, Aesun; Noh, Dong-Young; Ahn, Sei-Hyun; Hirvonen, Ari; Kang, Daehee

A phase II trial of imatinib mesylate monotherapy in patients with metastatic breast cancer
pp. 157-163(7)
Authors: Modi, Shanu; Seidman, Andrew; Dickler, Maura; Moasser, Mark; D’Andrea, Gabriella; Moynahan, Mary; Menell, Jennifer; Panageas, Katherine; Tan, Lee; Norton, Larry; Hudis, Clifford

The CHEK2 c.1100delC germline mutation rarely contributes to breast cancer development in the Czech Republic
pp. 165-167(3)
Authors: Kleibl, Zdenek; Novotny, Jan; Bezdickova, Drahomira; Malik, Radek; Kleiblova, Petra; Foretova, Lenka; Petruzelka, Lubos; Ilencikova, Denisa; Cinek, Petr; Pohlreich, Petr

Primary docetaxel chemotherapy in patients with breast cancer: impact on response and survival
pp. 169-185(17)
Authors: Heys, Steven; Sarkar, Tarun; Hutcheon, Andrew

Pathology of breast cancer in women with constitutional CHEK2 mutations
pp. 187-189(3)
Authors: Huzarski, Tomasz; Cybulski, Cezary; Domagaa, Wenancjusz; Gronwald, Jacek; Byrski, Tomasz; Szwiec, Marek; Woyke, Stanisaw; Narod, Steven; Lubiski, Jan

Is stereotactic large-core needle biopsy beneficial prior to surgical treatment in BI-RADS 5 lesions?
pp. 191-191(1)
Authors: Verkooijen, H.; Vlastos, G.; Kinkel-Trugli, K.

Updates on SABCS 2004 abstracts
pp. 193-214(22)